Health
Siriraj Hospital and Affinome Unveil New Innovation for Brain and Central Nervous System Cancer Treatment
Thailand's Siriraj Hospital has partnered with Affinome to introduce a new medical innovation aimed at treating brain and central nervous system cancers.
According to a report by Matichon Online published on September 16, 2026, the Faculty of Medicine Siriraj Hospital has collaborated with the medical technology firm Affinome to launch a new innovation designed for the treatment of patients suffering from brain and central nervous system cancers.
This development represents a significant step in local medical advancement. For residents and long-term expatriates in Thailand, the availability of advanced oncology treatments at a leading institution like Siriraj Hospital may enhance access to specialized care for complex neurological conditions. While the announcement highlights the introduction of this new product, specific details regarding the clinical availability, patient eligibility criteria, and the full scope of the treatment protocol remain to be confirmed by the hospital authorities.
As this is a specialized medical development, those seeking information regarding personal health or treatment options should consult directly with medical professionals at Siriraj Hospital. The report serves as an update on institutional progress in medical technology rather than a guarantee of specific outcomes for individual patients. Further updates from the hospital are expected as the innovation is integrated into their clinical practice.